GSE128730 neratinib OVCAR-8 4 v 2 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE128730_neratinib_OVCAR-8_4_v_2_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE128730_neratinib_OVCAR-8_4_v_2_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE128730_neratinib_OVCAR-8_4_v_2_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE128730_neratinib_OVCAR-8_4_v_2_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

DnaJ heat shock protein family (Hsp40) member A3

Gene

tissue factor pathway inhibitor 2

Gene

dickkopf Wnt signaling pathway inhibitor 1

Gene

metallothionein 1E

Gene

3-hydroxy-3-methylglutaryl-CoA synthase 1

Gene

stearoyl-CoA desaturase

Gene

tubulin beta 2A class IIa

Gene

plasminogen activator, tissue type

Gene

serglycin

Gene

cellular communication network factor 2

  • Gene

    DnaJ heat shock protein family (Hsp40) member A3


  • Gene

    tissue factor pathway inhibitor 2


  • Gene

    dickkopf Wnt signaling pathway inhibitor 1


  • Gene

    metallothionein 1E


  • Gene

    3-hydroxy-3-methylglutaryl-CoA synthase 1


  • Gene

    stearoyl-CoA desaturase


  • Gene

    tubulin beta 2A class IIa


  • Gene

    plasminogen activator, tissue type



  • Gene

    cellular communication network factor 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.